DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Tech
Updated 1m ago
ZEPP logo

Zepp Health CorporationNYSE:ZEPP Stock Report

Market Cap US$63.4m
Updated 1m ago
Share Price
n/a
1Y-91.0%
7D-5.7%
1D-1.8%
Portfolio Value
​
View

Zepp Health Corporation

NYSE:ZEPP Stock Report

Market Cap: US$63.4m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Zepp Health (ZEPP) Stock Overview

Operates as a smart wearable and health technology company worldwide. More details

ZEPP fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 98% below our estimate of its fair value

Earnings are forecast to grow 161.93% per year

Trading at good value compared to peers and industry

Risk Analysis

Does not have a meaningful market cap ($63M)


ZEPP Community Fair Values

Create Narrative

See what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
92.8% undervalued intrinsic discount
AnalystConsensusTarget
•1y ago

GDPR Pressures And AI Health Developments Will Shape Future Markets

164
0
14

Top Analyst Narratives

ZEPP logo
Zepp Health
92.8% undervalued intrinsic discount

GDPR Pressures And AI Health Developments Will Shape Future Markets

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 23 Aug 2025
Read Narrative
View all narratives

Zepp Health Corporation Competitors

Wrap Technologies

Symbol: NasdaqCM:WRAP
Market cap: US$93.9m

ZRCN

Symbol: OTCPK:ZRCN
Market cap: US$72.3m

Arbe Robotics

Symbol: NasdaqCM:ARBE
Market cap: US$85.3m

MicroVision

Symbol: NasdaqCM:MVIS
Market cap: US$39.5m

Price History & Performance

Summary of share price highs, lows and changes for Zepp Health
Historical stock prices
Current Share PriceUS$4.32
52 Week HighUS$61.85
52 Week LowUS$3.85
Beta1.89
1 Month Change-16.12%
3 Month Change-10.74%
1 Year Change-91.00%
3 Year Change-4.42%
5 Year Change-87.63%
Change since IPO-90.40%

Recent News & Updates

Recent updates

Seeking Alpha • Apr 19

Zepp Health: A Riskier Bet As Gross Margins Compress (Rating Downgrade)

Summary Zepp Health has shifted from a buy to a neutral rating due to persistent unprofitability and margin concerns. Despite >40% y/y revenue growth in Amazfit, ZEPP faces tough comps and macro headwinds that threaten sustained double-digit expansion. Gross margins remain in the high 30s, ~20 points below Garmin, limiting ZEPP’s scalability and profit potential. With abundant high-quality software bargains available, I see little justification to maintain or add to ZEPP positions. Read the full article on Seeking Alpha
Analysis Article • Jan 08

Investors Aren't Entirely Convinced By Zepp Health Corporation's (NYSE:ZEPP) Revenues

With a price-to-sales (or "P/S") ratio of 2x Zepp Health Corporation ( NYSE:ZEPP ) may be sending bullish signals at...
Analysis Article • Sep 23

Market Participants Recognise Zepp Health Corporation's (NYSE:ZEPP) Revenues Pushing Shares 28% Higher

Despite an already strong run, Zepp Health Corporation ( NYSE:ZEPP ) shares have been powering on, with a gain of 28...
Analysis Article • Aug 24

Just In: One Analyst Has Become A Lot More Bullish On Zepp Health Corporation's (NYSE:ZEPP) Earnings

Zepp Health Corporation ( NYSE:ZEPP ) shareholders will have a reason to smile today, with the covering analyst making...
User avatar
Narrative Update • Aug 23

GDPR Pressures And AI Health Developments Will Shape Future Markets

Zepp Health's consensus price target has surged, primarily reflecting sharply higher expected revenue growth and a much richer projected valuation multiple, now placing fair value at $60.23. What's in the News Zepp Health issued Q3 2025 revenue guidance of $72–76 million, projecting a 23–35% year-over-year increase from $42.5 million.
Analysis Article • Aug 04

Zepp Health Corporation (NYSE:ZEPP) Soars 336% But It's A Story Of Risk Vs Reward

Zepp Health Corporation ( NYSE:ZEPP ) shareholders have had their patience rewarded with a 336% share price jump in the...
Analysis Article • Apr 18

Investors Give Zepp Health Corporation (NYSE:ZEPP) Shares A 29% Hiding

Zepp Health Corporation ( NYSE:ZEPP ) shares have had a horrible month, losing 29% after a relatively good period...
User avatar
New Narrative • Apr 12

AI-powered T-Rex 3 And Amazfit Releases Will Redefine Future Possibilities

Transition to a high-margin business model and AI-powered product launches likely to enhance profitability and drive significant revenue growth.
Analysis Article • Aug 20

Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Zepp Health Corporation ( NYSE:ZEPP ) shareholders are no doubt pleased to see that the share price has bounced 26% in...
Analysis Article • Aug 03

Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Zepp Health fair value estimate is US$0.56 Zepp Health's...
Analysis Article • Apr 17

Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

To the annoyance of some shareholders, Zepp Health Corporation ( NYSE:ZEPP ) shares are down a considerable 27% in the...
Analysis Article • Dec 23

Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

The Zepp Health Corporation ( NYSE:ZEPP ) share price has done very well over the last month, posting an excellent gain...
Seeking Alpha • Nov 24

Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales

Summary Zepp returned to profitability in the third quarter for the first time since 2021, as its margins jumped with the development of its own Amazfit brand. The company’s shares initially rose sharply after the report, but then fell even more, as investors worried about a big drop in sales of its own-brand products. Zepp’s latest valuation metrics look ridiculously low, including a forward P/E ratio of just 3.1 and a P/S ratio of 0.14. Read the full article on Seeking Alpha
Seeking Alpha • Jul 31

Can Zepp Health Find Its Way Back Up?

Summary Zepp Health has had the most tumultuous two years. The share price plummeted 88%, and revenue is down by almost 50%. At this point, is ZEPP stock worth investing in? Read the full article on Seeking Alpha

Shareholder Returns

ZEPPUS ElectronicUS Market
7D-5.7%-5.0%-0.2%
1Y-91.0%38.7%12.1%

Return vs Industry: ZEPP underperformed the US Electronic industry which returned 38.7% over the past year.

Return vs Market: ZEPP underperformed the US Market which returned 12.1% over the past year.

Price Volatility

Is ZEPP's price volatile compared to industry and market?
ZEPP volatility
ZEPP Average Weekly Movement9.8%
Electronic Industry Average Movement9.0%
Market Average Movement6.8%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market2.9%

Stable Share Price: ZEPP has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ZEPP's weekly volatility has decreased from 15% to 10% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013763Wayne Huangwww.zepp.com

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories.

Zepp Health Corporation Fundamentals Summary

How do Zepp Health's earnings and revenue compare to its market cap?
ZEPP fundamental statistics
Market capUS$63.35m
Earnings (TTM)-US$43.56m
Revenue (TTM)US$276.03m
0.2x
P/S Ratio
-1.5x
P/E Ratio

Is ZEPP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZEPP income statement (TTM)
RevenueUS$276.03m
Cost of RevenueUS$169.52m
Gross ProfitUS$106.50m
Other ExpensesUS$150.06m
Earnings-US$43.56m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-2.97
Gross Margin38.58%
Net Profit Margin-15.78%
Debt/Equity Ratio72.0%

How did ZEPP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 07:05
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zepp Health Corporation is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ang-Chi LinCitigroup Inc
Siddharth RajeevFundamental Research Corp.
Jones KuHaitong International Research Limited

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide